Postpartum Hemorrhage — Effect of Adjunctive Misoprostol Treatment on Blood Loss at Vaginal Delivery
Citation(s)
Baruah M, Cohn GM Efficacy of rectal misoprostol as second-line therapy for the treatment of primary postpartum hemorrhage. J Reprod Med. 2008 Mar;53(3):203-6.
Cabrera Y, Fernández-Guisasola J, Lobo P, Gámir S, Alvarez J Comparison of sublingual versus vaginal misoprostol for second-trimester pregnancy termination: a meta-analysis. Aust N Z J Obstet Gynaecol. 2011 Apr;51(2):158-65. doi: 10.1111/j.1479-828X.2010.01264.x. Epub 2011 Jan 6.
Elati A, Elmahaishi MS, Elmahaishi MO, Elsraiti OA, Weeks AD The effect of misoprostol on postpartum contractions: a randomised comparison of three sublingual doses. BJOG. 2011 Mar;118(4):466-73. doi: 10.1111/j.1471-0528.2010.02821.x. Epub 2010 Dec 24.
Garris RE, Kirkwood CF Misoprostol: a prostaglandin E1 analogue. Clin Pharm. 1989 Sep;8(9):627-44. Review.
Gemzell-Danielsson K, Bygdeman M, Aronsson A Studies on uterine contractility following mifepristone and various routes of misoprostol. Contraception. 2006 Jul;74(1):31-5. Epub 2006 Apr 27. Review.
Haque N, Bilkis L, Haque N, Bari MS, Haque S Comparative study between rectally administered misoprostol as a prophylaxis versus conventional intramuscular oxytocin in post partum hemorrhage. Mymensingh Med J. 2009 Jan;18(1 Suppl):S40-44.
Mansouri HA, Alsahly N Rectal versus oral misoprostol for active management of third stage of labor: a randomized controlled trial. Arch Gynecol Obstet. 2011 May;283(5):935-9. doi: 10.1007/s00404-010-1466-5. Epub 2010 Apr 27.
Nasr A, Shahin AY, Elsamman AM, Zakherah MS, Shaaban OM Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage. Int J Gynaecol Obstet. 2009 Jun;105(3):244-7. doi: 10.1016/j.ijgo.2009.01.018. Epub 2009 Feb 26.
Pontieri-Lewis V The role of nutrition in wound healing. Medsurg Nurs. 1997 Aug;6(4):187-90, 221; quiz 191-2. Review.
Pritchard JA, Baldwin RM, Dickey JC, et al Blood volume changes in pregnancy and the puerperium, 2. Red blood cell loss and changes in apparent blood volume during and following vaginal delivery, cesarean section, and cesarean section plus total hysterectomy. Am J Obstet Gynecol 1962;84:1271-1282.
Soltani H, Hutchon DR, Poulose TA Timing of prophylactic uterotonics for the third stage of labour after vaginal birth. Cochrane Database Syst Rev. 2010 Aug 4;(8):CD006173. doi: 10.1002/14651858.CD006173.pub2. Review.
Sosa CG, Althabe F, Belizán JM, Buekens P Risk factors for postpartum hemorrhage in vaginal deliveries in a Latin-American population. Obstet Gynecol. 2009 Jun;113(6):1313-1319. doi: 10.1097/AOG.0b013e3181a66b05.
Tang OS, Schweer H, Lee SW, Ho PC Pharmacokinetics of repeated doses of misoprostol. Hum Reprod. 2009 Aug;24(8):1862-9. doi: 10.1093/humrep/dep108. Epub 2009 Apr 23.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
